High Resolution Diffusion Weighted Imaging in Prostate
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age55+
SponsorThe First Affiliated Hospital with Nanjing Medical University
About this trial
hrDWI might be an alternative to cDWI for the prostate imaging.
1. increase the signal-to-noise ratio and contrast-to-noise ratio, yielding high-fidelity images with less noise in general 2. improve the diagnostic accuracy of PCa in particular than conventional DWI
Eligibility criteria
Qualifiers
Patients who underwent standard MR scanning including T2WI, cDWI , hrDWI and respective calculated apparent diffusion coefficient (ADC) maps;
Complete clinical information.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov